Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Bioavailability of 99mTc-paclitaxel-glucuronide (99mTc-PAC-G)

View through CrossRef
Abstract An antitumor agent paclitaxel (PAC) has been proved to be efficient in the treatment of breast and ovarian cancer. Glucuronic acid-derived paclitaxel compound [paclitaxel-glucuronide (PAC-G)] was enzymatically synthesized using microsome preparate separated from rat livers. The biodistribution mechanism of PAC-G in healthy female Albino Wistar rats has been investigated. The expected structure is confirmed according to LC/MS results, and the possible attachment is to C2-hydroxyl group. PAC-G was labeled with 99mTc and the radiochemical yield of radiolabeled compound (99mTc-PAC-G) was 98.0±02.74 (n=9). The range of the breast/blood and breast/muscle ratios is approximately between 3 and 35 in 240ߙmin. All these experimental studies indicate that 99mTc-PAC-G may potentially be used in breast tissue as an imaging agent.
Title: Bioavailability of 99mTc-paclitaxel-glucuronide (99mTc-PAC-G)
Description:
Abstract An antitumor agent paclitaxel (PAC) has been proved to be efficient in the treatment of breast and ovarian cancer.
Glucuronic acid-derived paclitaxel compound [paclitaxel-glucuronide (PAC-G)] was enzymatically synthesized using microsome preparate separated from rat livers.
The biodistribution mechanism of PAC-G in healthy female Albino Wistar rats has been investigated.
The expected structure is confirmed according to LC/MS results, and the possible attachment is to C2-hydroxyl group.
PAC-G was labeled with 99mTc and the radiochemical yield of radiolabeled compound (99mTc-PAC-G) was 98.
0±02.
74 (n=9).
The range of the breast/blood and breast/muscle ratios is approximately between 3 and 35 in 240ߙmin.
All these experimental studies indicate that 99mTc-PAC-G may potentially be used in breast tissue as an imaging agent.

Related Results

Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract INTRODUCTION: Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and is typified by poor outcomes. G...
Abstract B14: A novel strategy for the treatment of melanoma
Abstract B14: A novel strategy for the treatment of melanoma
Abstract Introduction: Approximately 76,000 individuals are diagnosed with melanoma, and about 9,000 die as a result of the disease each year in the United States. E...
Pharmacokinetic Evaluation of 99mTc-radiolabeled Solid Lipid Nanoparticles and Chitosan Coated Solid Lipid Nanoparticles
Pharmacokinetic Evaluation of 99mTc-radiolabeled Solid Lipid Nanoparticles and Chitosan Coated Solid Lipid Nanoparticles
Background: Solid Lipid Nanoparticles (SLNs) possess unique in vivo features such as high resistivity, bioavailability, and habitation at the target site. Coating nanoparticles wit...
Non-Invasive Measurement of Microvascular Permeability to a Small Solute in Man: Validation of the Technique
Non-Invasive Measurement of Microvascular Permeability to a Small Solute in Man: Validation of the Technique
1. The purpose of the study was to evaluate a non-invasive technique for measurement of microvascular permeability to a small hydrophilic solute. 2. The technique me...
Investigation on genetic control for yield and yield contributing traits in advanced generation of maize (Zea mays L.)
Investigation on genetic control for yield and yield contributing traits in advanced generation of maize (Zea mays L.)
Twenty five cross progeny of maize developed by Plant Breeding Division of BARI were evaluated by determining general combining ability (GCA) and specific combining ability (SCA) e...
Phase I Dose-Finding and Pharmacokinetic Study of Paclitaxel and Carboplatin With Oral Valspodar in Patients With Advanced Solid Tumors
Phase I Dose-Finding and Pharmacokinetic Study of Paclitaxel and Carboplatin With Oral Valspodar in Patients With Advanced Solid Tumors
PURPOSE: To evaluate the maximum-tolerated dose (MTD), dose-limiting toxicities (DLTs), and pharmacokinetic (PK) profile of paclitaxel and carboplatin when administered every 3 wee...
A Taxane Total Cost of Care Analysis in Metastatic Breast Cancer: Results of Private Payor Claims Data.
A Taxane Total Cost of Care Analysis in Metastatic Breast Cancer: Results of Private Payor Claims Data.
Abstract Background: It has been estimated that over $8 billion is spent annually on the management of breast cancer in the US. The taxane chemotherapeutic agents ar...

Back to Top